GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector
GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading…
News
Inivata and Collaborators to Present New Data Further Validating the Application of its RaDaR® MRD and InVisionFirst®-Lung Tests at the 2022 ASCO Annual Meeting
Inivata and Collaborators to Present New Data Further Validating the Application of its RaDaR® MRD…
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland
For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject®Surgeries in Switzerland The only…
Phase 2a study results in binge eating disorder
Allschwil, Switzerland – May 10, 2022 Idorsia Ltd (SIX: IDIA) today announced that ACT-539313, a…
Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people…
ScreenPro Provides Update on Business Operations
Toronto, Ontario–(Newsfile Corp. – May 10, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
Hitachi High-Tech and Invivoscribe Partner to Advance Molecular Diagnostics
TOKYO, May 10, 2022 – (JCN Newswire) – Hitachi High-Tech Corporation has entered into a…
Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer’s Disease Under the Accelerated Approval Pathway
TOKYO and CAMBRIDGE, Mass., May 10, 2022 – (JCN Newswire) – Eisai Co., Ltd. and…
MTarget Selects iBASIS to Introduce CPaaS Mobile Marketing Campaigns via APIs
Leveraging omni channel capabilities by powering voice channels as a carrier-grade, enterprise-centric CPaaS for service…
CLINUVEL progresses vitiligo treatment program
Novel approach to addressing pigment loss disorder affecting an estimated 45 million individuals worldwide Vitiligo…
Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy
Company announcement – No. 16/ 2022 Zealand Pharma Amends Financing Agreement with Oberland Capital as…
Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan
TOKYO, May 10, 2022 – (JCN Newswire) – Eisai Co., Ltd. today announced that it…
Broad Homes Utilizes Intelligent Manufacturing System to Expand into Smart Buildings
HONG KONG, May 10, 2022 – (ACN Newswire) – Broad Homes and Tencent Cloud enter…
Trellix Accelerates Growth in First 100 Days
Company Leading the Extended Detection and Response (XDR) Market Transition News Highlights Trellix momentum continues…
Heliogen, Inc. to Reschedule Release of First Quarter 2022 Earnings Results and Conference Call
PASADENA, Calif.–(BUSINESS WIRE)–Heliogen, Inc. (“Heliogen”) (NYSE: HLGN), a leading provider of AI-enabled concentrated solar energy…
Samsung Electronics Introduces Industry’s First 512GB CXL Memory Module
Newly developed CXL memory packs 4x the memory capacity over the previous version, enabling a…
TraceSafe Announces Cease Trade Order and Provides Update To Shareholders on Status of Financial Statements
Expects to Complete the Annual Filing on or Before May 13 Vancouver, British Columbia–(Newsfile Corp….
AMAZON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Amazon.com, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update
SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical…
Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results
Data from COVID-19 Phase II study and norovirus Phase IB study are expected in 2022…